New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...
Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant outcomes, researchers said at the Conference on Retroviruses and Opportunistic ...
The cuts have had a huge impact on global efforts to combat HIV, tuberculosis, malaria and other health scourges, putting ...
A yearly injection such as Lenacapavir could help overcome barriers to PrEP accessibility by increasing its uptake and making ...
On March 7, 2025, and again on March 10, scientists, healthcare workers, and more rallied in protest to Trump administration ...
New research into how a retrovirus is spreading across populations of wild koalas in Queensland, Australia is leading to a ...
It would be hard to ask for a better week of original programming than the one just handed to us by the major streamers. Amazon has the big-budget fantasy series, The Wheel of Time, back for its ...
With an at least $60 billion total addressable market, the liquid biopsy sector offers abundant opportunity for multiple companies to swim to the top. The six largest companies in the pool have just ...